Evidence map›Paper›PMID 26438321›Full record

ArticleBMC gastroenterology2015

Factors associated with growth disturbance at celiac disease diagnosis in children: a retrospective cohort study.

Samuli Nurminen, Laura Kivelä, Juha Taavela, Heini Huhtala, Markku Mäki, Katri Kaukinen, Kalle Kurppa

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
3.1field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 48 citations in OpenAlex.

  1. Observational
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Type 1 tyrosinemia in Finland: a nationwide study.Orphanet journal of rare diseases · 2020
    Article
  16. Article
  17. Article
  18. Failure to Thrive: An Expanded Differential Diagnosis.Journal of pediatric genetics · 2019
    Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Samuli NurminenSchool of Medicine, University of Tampere, FIN-33014, Tampere, Finland. nurminen.samuli.j@student.uta.fi.
Laura KiveläSchool of Medicine, University of Tampere, FIN-33014, Tampere, Finland. laura.kivela@fimnet.fi.
Juha TaavelaTampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland. juha.taavela@uta.fi.
Heini HuhtalaSchool of Health Sciences, University of Tampere, Tampere, Finland. heini.huhtala@staff.uta.fi.
Markku MäkiTampere Center for Child Health Research, University of Tampere and Tampere University Hospital, Tampere, Finland. markku.maki@uta.fi.
Katri KaukinenSchool of Medicine, University of Tampere, FIN-33014, Tampere, Finland. katri.kaukinen@uta.fi.
Kalle KurppaSchool of Medicine, University of Tampere, FIN-33014, Tampere, Finland. kalle.kurppa@uta.fi.
Tampere University · FITampere University · FITampere University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundImpaired growth is a well-known complication in celiac disease, but factors associated with it are poorly known. We investigated this issue in a large cohort of children.

methods530 children with biopsy-proven celiac disease were included. The participants were divided into two groups on the basis of the presence (n = 182) or absence (n = 348) of growth disturbance at diagnosis. Histological, serological and clinical characteristics were compared between children with growth failure and those with normal growth. Further, patients with growth failure as the sole clinical presentation were compared to those with poor growth and concomitant other symptoms.

resultsChildren with growth failure were younger (p < 0.001) and had lower hemoglobin (p = 0.016) and higher celiac antibody (p < 0.001), alanine aminotransferase (p = 0.035) and thyroid-stimulating hormone values (p = 0.013) than those with normal growth. Significantly associated with growth failure at diagnosis were age <3 years (OR 4.3 (95 % CI 2.5-7.5) vs older age), diagnosis before the year 2000 and in 2000-09 (OR 3.1 (1.8-5.4) and OR 1.8 (1.1-2.8) vs diagnosis in 2010-2013), presence of total and subtotal villous atrophy (OR 4.2 (2.5-7.0) and OR 2.0 (1.3-3.2) vs partial atrophy), severe symptoms (OR 3.4 (1.8-6.7) vs mild symptoms) and vomiting (OR 3.1 (1.5-6.3). The presence of abdominal pain reduced the risk (OR 0.5 (0.3-0.7)), while there was no effect of gender, diarrhea, constipation, other chronic diseases and celiac disease in the family. Children evincing poor growth as the sole clinical presentation were older (p < 0.001) and had higher hemoglobin (P < 0.001) and total iron (p = 0.010) values and lower TG2ab values (p = 0.009) than those with growth disturbance and other symptoms.

conclusionsIn particular young age and severe clinical and histological presentation were associated with growth disturbance at celiac disease diagnosis. Children with only poor growth are markedly different from those with other concomitant symptoms, suggesting different pathogenic mechanisms.

Indexed as

Abdominal PainAge FactorsAge of OnsetAlanineAntibodiesAtrophyCeliac DiseaseChildChild, PreschoolFailure to ThriveFemaleGrowth DisordersGTP-Binding ProteinsHemoglobinsHumansIntestinesAlanineAntibodiesGTP-Binding ProteinsHemoglobinsIronProtein Glutamine gamma Glutamyltransferase 2ThyrotropinTransaminasesTransglutaminases

Identifiers

PMID26438321
PMCPMC4595273
OpenAlexW1870620377

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.